XWELL (NASDAQ:XWEL) Upgraded by Wall Street Zen to “Hold” Rating

Wall Street Zen upgraded shares of XWELL (NASDAQ:XWEL) from a sell rating to a hold rating in a report published on Saturday.

Separately, Weiss Ratings upgraded XWELL from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, April 29th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat.com, XWELL presently has a consensus rating of “Sell”.

XWELL Price Performance

Shares of XWELL stock opened at $1.47 on Friday. The firm has a market cap of $11.65 million, a price-to-earnings ratio of -0.29 and a beta of 1.01. XWELL has a 52-week low of $0.26 and a 52-week high of $2.20. The stock has a 50-day simple moving average of $1.28 and a 200-day simple moving average of $0.86.

XWELL (NASDAQ:XWEL) last posted its earnings results on Wednesday, April 1st. The company reported ($3.29) earnings per share for the quarter. XWELL had a negative return on equity of 352.37% and a negative net margin of 58.17%.The company had revenue of $7.15 million during the quarter.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.